Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Briel

Showing results (261-270 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Epidemiology|November 13, 2015
Systematic reviews experience major limitations in reporting absolute effectsPablo Alonso-Coello, Alonso Carrasco-Labra, Romina Brignardello-Petersen, et al.
Journal of Clinical Epidemiology|April 9, 2017
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidenceVivian A Welch, Elie A Akl, Kevin Pottie, et al.
Journal of Clinical Epidemiology|August 25, 2016
Authors seldom report the most patient-important outcomes and absolute effect measures in systematic review abstractsArnav Agarwal, Bradley C Johnston, Robin W M Vernooij, et al.
BMC Medical Research Methodology|August 30, 2012
Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)Benjamin Kasenda, Erik B von Elm, John You, et al.
Systematic Reviews|December 17, 2013
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocolPablo Alonso-Coello, Alonso Carrasco-Labra, Romina Brignardello-Petersen, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
BMJ Open|May 25, 2022
Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)Dmitry Gryaznov, Belinda von Niederhäusern, Benjamin Speich, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Journal of Clinical Epidemiology|May 24, 2021
Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional studySzimonetta Lohner, Dmitry Gryaznov, Belinda von Niederhäusern, et al.
Trials|October 29, 2020
Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projectsDmitry Gryaznov, Ayodele Odutayo, Belinda von Niederhäusern, et al.
Pageof 29

Showing results (261-270 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Epidemiology|November 13, 2015
Systematic reviews experience major limitations in reporting absolute effectsPablo Alonso-Coello, Alonso Carrasco-Labra, Romina Brignardello-Petersen, et al.
Journal of Clinical Epidemiology|April 9, 2017
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidenceVivian A Welch, Elie A Akl, Kevin Pottie, et al.
Journal of Clinical Epidemiology|August 25, 2016
Authors seldom report the most patient-important outcomes and absolute effect measures in systematic review abstractsArnav Agarwal, Bradley C Johnston, Robin W M Vernooij, et al.
BMC Medical Research Methodology|August 30, 2012
Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study)Benjamin Kasenda, Erik B von Elm, John You, et al.
Systematic Reviews|December 17, 2013
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocolPablo Alonso-Coello, Alonso Carrasco-Labra, Romina Brignardello-Petersen, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
BMJ Open|May 25, 2022
Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)Dmitry Gryaznov, Belinda von Niederhäusern, Benjamin Speich, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Journal of Clinical Epidemiology|May 24, 2021
Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional studySzimonetta Lohner, Dmitry Gryaznov, Belinda von Niederhäusern, et al.
Trials|October 29, 2020
Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projectsDmitry Gryaznov, Ayodele Odutayo, Belinda von Niederhäusern, et al.
Pageof 29